Skip to content

TuHURA Biosciences, Inc. HURA Book value per share

Book value per share at other companies

CTO
Citius Oncology, Inc.CTOR
$0.35-29.2%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
-$1.35-122%
Corvus Pharmaceuticals logo
Corvus PharmaceuticalsCRVS
$2.67+307%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-$0.85-22.2%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$3.40-70.9%
Janux Therapeutics logo
Janux TherapeuticsJANX
$15.02-8.3%

Other financials

Income statement

See full
Revenue-
Net income-$7.5M-13.1%
EPS (diluted)-$0.13+13.3%

Balance sheet

See full
Cash & equivalents$6.3M+1.3%
Total debt$456.9K+178%
Total equity$23.2M+135%
Total assets$29.7M+103%

Cash flow

See full
Operating cash flow-$4.4M+6.9%
CapEx$48.8K+14.5%
Free cash flow-$4.5M+6.7%

Valuation

See full
Market cap$155.39M+45.8%
Enterprise value$149.54M+52.3%

Returns & leverage

See full
Return on equity-187.2%
Debt / equity0.0×
Current ratio1.2×-1.8×

Where this comes from

Calculated from TuHURA Biosciences, Inc.’s reported figures.

Based on the most recent quarter.

The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about TuHURA Biosciences, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TuHURA Biosciences, Inc.'s book value per share?
TuHURA Biosciences, Inc. (HURA) reported book value per share of $0.39 in Q1 2026.
How has TuHURA Biosciences, Inc.'s book value per share changed year-over-year?
TuHURA Biosciences, Inc.'s book value per share increased by 70.1% year-over-year, from $0.23 to $0.39.
What is the long-term trend for TuHURA Biosciences, Inc.'s book value per share?
Over 2 years (2023 to 2025), TuHURA Biosciences, Inc.'s book value per share has grown at a 82.5% compound annual growth rate (CAGR), from -$0.13 to $0.44.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.